Telix’s Illuccix prostate cancer PSMA-PET imaging agent approved in the Netherlands: Melbourne, Australia Wednesday, March 19, 2025, 12:00 Hrs [IST] Telix, a biopharmaceutical c ...
Stockhead on MSN19h
Biocurious: FDA approval remains the Holy Grail for ASX life science stocksDespite the Trump administration's shake-up of the agency, the US FDA is the first port of call for most ASX biotechs.
Wilsons analyst Shane Storey maintained a Buy rating on EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (EBR – Research Report) ...
Medical imaging today faces several critical challenges. Imaging modalities like MRI, PET, and CT are used in over five hundred million patients annually for diagnosis and treatment, involving long ...
Delivering late stage therapeutic pipeline, building the next generation of radiopharmaceuticals, growing industry leading precision medicine business, expanding global infrastructure for product ...
Finally, energy shares escaped unscathed, as you can see from the S&P/ASX 200 Energy Index (ASX: XEJ)'s 0.03% bump. Today's ...
Market Index on MSN12h
Evening Wrap: ASX 200 slides despite gains in uranium, critical metals, and battery stocks, MIN dumps on haul road woesThe S&P/ASX 200 closed 32.1 points lower, down 0.41%. Uranium stocks saw another steady day of gains today as the uranium ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback